| 000 | 01707 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513190340.0 | ||
| 264 | 0 | _c19990830 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0002-8703 | ||
| 024 | 7 |
_a10.1016/s0002-8703(99)70338-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerguson, J J | |
| 245 | 0 | 0 |
_aIIb/IIIa receptor blockade in acute myocardial infarction. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cAug 1999 |
||
| 300 |
_aS164-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 |
_aBlood Platelets _xphysiology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCoronary Thrombosis _xetiology |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 | _aMyocardial Reperfusion |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPlatelet Glycoprotein GPIb-IX Complex |
| 650 | 0 | 4 | _aPlatelet Membrane Glycoproteins |
| 650 | 0 | 4 |
_aReceptors, Antigen, B-Cell _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aTaqi, K | |
| 773 | 0 |
_tAmerican heart journal _gvol. 138 _gno. 2 Pt 2 _gp. S164-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-8703(99)70338-8 _zAvailable from publisher's website |
| 999 |
_c10384815 _d10384815 |
||